GlassScriptPrepare for your visit
Kavitha Raman
Family · Dallas, TX · NPI 1548922602
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,014.60
in general payments reported to CMS, 2019-2025 · $891 in 2025
The $891 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Collegium Pharmaceutical, INC. $306.27
- Tersera Therapeutics LLC $159.99
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $124.31
- Biotronik Nro, INC. $103.94
- Valinor Pharma, LLC $80.20
- Vertex Pharmaceuticals Incorporated $67.52
Drugs and devices associated with these payments
Relistor Prialt Nucynta Xtampza Prospera Movantik Journavx Nalu Neurostimulation System Qutenza Ubrelvy Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A Intracept
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kavitha Raman listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11270736/kavitha-raman